532523:BOM
Biocon Ltd
350,00 INR
arrow_downward
-0,43%(-1,50) 1D
16-окт., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
352,95 INR
High
352,95 INR
Low
348,10 INR
Mkt. cap
568,79 млд
Avg. vol.
692,61 миң
Volume
668,34 миң
Dividend
0,14%
Quarterly dividend
0,13 INR
Ex-dividend date
2026-ж., 3-июл.
P/E ratio
103,62
52-wk high
447,00 INR
52-wk low
337,95 INR
EPS
3,38 INR
Shares outstanding
600,00 млн
No. of employees
16 миң
Open
352,95 INR
High
352,95 INR
Low
348,10 INR
Mkt. cap
568,79 млд
Avg. vol.
692,61 миң
Volume
668,34 миң
Dividend
0,14%
Quarterly dividend
0,13 INR
Ex-dividend date
2026-ж., 3-июл.
P/E ratio
103,62
52-wk high
447,00 INR
52-wk low
337,95 INR
EPS
3,38 INR
Shares outstanding
600,00 млн
No. of employees
16 миң
News stories
From web sources and news partners
tech-insider.org
·
1 саат мурун
Trump Calls AI Warnings ‘HOAX’, Nasdaq Drops 0.9% [2026]
Yahoo Finance
·
15 саат мурун
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
1 күн мурун
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Investor's Business Daily
·
3 саат мурун
Dow Jones Futures: What To Do After S&P 500, Nasdaq Break Support; Will Meta Earnings Save AI?
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16,4 миң
Founded1978-ж., 29-ноя.
HeadquartersБенгалуру, Карнатака, Индия
Sector-
Websitebiocon.com